Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2007
10/25/2007US20070249048 useful as immunosuppressive, anti-inflammatory and anticancer agents; prepared by reaction of a starting triptolide compound with selenium dioxide.
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248701 Methods and formulations for inhibiting naturally occurring phosphodiesterase
10/25/2007US20070248663 Utilization of Dialkylfumerates
10/25/2007US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007US20070248624 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
10/25/2007US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248615 T helper cell epitopes
10/25/2007US20070248614 Vaccination
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248577 Methods and compositions for administering stem cells
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007US20070248545 Use of the receptor GPR86
10/25/2007CA2649440A1 Methods of treating autoimmune diseases
10/25/2007CA2649302A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007CA2649290A1 Allogeneic cell therapy for treatment of opportunistic infection
10/24/2007EP1847602A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847182A2 Foodstuffs or dietary supplements containing flavonoid derivates
10/24/2007EP1846441A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof
10/24/2007EP1846428A1 Anti-inflammatory conjugates of macrolides and coumarins
10/24/2007EP1846409A1 Octahydropyrrolo[3,4-c]pyrrole derivatives
10/24/2007EP1846404A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
10/24/2007EP1846391A2 Raf inhibitor compounds and methods
10/24/2007EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
10/24/2007EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
10/24/2007EP1846031A1 Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent
10/24/2007EP1845970A2 Tumor necrosis factor inhibitors
10/24/2007EP1845967A2 A method of modulating t cell functioning
10/24/2007EP1845780A2 Uses of methylphenidate derivatives
10/24/2007EP1658081B1 Immunosuppressive effects of pteridine derivatives
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061140A Compositions monovalent for CD40L binding and methods of use
10/24/2007CN101061138A T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN101060858A Method for determining dosage of oral inactivation vaccine
10/24/2007CN101060851A Pharmaceuticals agents comprising blood components and/or kDa and their use for prophylaxis and treatment of defects of the immune system
10/24/2007CN101058800A Animal protein free media for cultivation of cells
10/24/2007CN101058786A Health care wine capable of eliminating sub-health for male and female, and preparation method thereof
10/24/2007CN101058610A Codonopsisbulleyana polysaccharide sulfate and use thereof
10/24/2007CN101058595A Ibonucleic acid, and preparation method and application thereof
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007CN101057976A Substances for preventing and treating autoimmune diseases
10/24/2007CN101057947A Capsule with sleep-improving sedative and brain-invigorating function
10/24/2007CN101057888A Traditional Chinese medicinal composition for regulating immunity and its preparation method and application
10/24/2007CN101057875A Medicine for curing allergic colitis
10/24/2007CN101057668A Functional health care beverage and preparation method
10/24/2007CN101057661A Extraction method for alpha-linolenic acid and preparation
10/24/2007CN101057614A Heat-clearing eyesight-improving bowels-relaxing health tea
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344311C Chinese medicine composition for treating nettle-rash and skin itch and its preparing method
10/24/2007CN100344308C Antisenescing and immunoregulating Chinese and Western medicinal mixture
10/24/2007CN100344295C Ganoderma lucidum capsule of lycopene
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285650 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
10/23/2007US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285539 Using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides and polynucleotides encoding them
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007US7285524 Allo and auto-reactive T-cell epitopes
10/23/2007US7285397 Gene expressing wasp poison allergen antigen 5 in bacteria in an insoluble form as inclusion bodies; denaturing using guanidine chloride without any reducing agent, and dialysis against acidic buffer; immunotherapy; genetic engineering
10/23/2007US7285282 Mucin peptide with immunoenhancing properties
10/23/2007US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007CA2272130C Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
10/23/2007CA2248266C Immunosuppressive compounds and methods
10/23/2007CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/18/2007WO2007117111A1 A phamaceutical composition for treating allergic diseases
10/18/2007WO2007116945A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116866A1 Hetero compound
10/18/2007WO2007115932A1 Thiazolyl-dihydroquinazolines
10/18/2007WO2007115813A1 Glycosylated antibodies
10/18/2007WO2007115713A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
10/18/2007WO2007115670A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007WO2007076228A8 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
10/18/2007WO2007059507A3 Compositions comprising lipoxygenase inhibitors and cyclodextrin
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007US20070244303 comprising an Fc region derived from a human IgG heavy chain, wherein the Fc region lacks effector function; for the reduction of a deleterious immune response; idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia
10/18/2007US20070244186 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases
10/18/2007US20070244060 Therapeutic Agent for Autoimmune Disease
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
1 ... 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 ... 1172